Your browser doesn't support javascript.
loading
Chemoresistance mechanisms of breast cancer and their countermeasures.
Ji, Xiwei; Lu, Yuan; Tian, Huifang; Meng, Xiangrui; Wei, Minji; Cho, William C.
Afiliação
  • Ji X; Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China. Electronic address: jjxxeezz@163.com.
  • Lu Y; Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
  • Tian H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Central Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.
  • Meng X; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Wei M; Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
  • Cho WC; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China. Electronic address: chocs@ha.org.hk.
Biomed Pharmacother ; 114: 108800, 2019 Jun.
Article em En | MEDLINE | ID: mdl-30921705
ABSTRACT
Chemoresistance is one of the major challenges for the breast cancer treatment. Owing to its heterogeneous nature, the chemoresistance mechanisms of breast cancer are complicated, and not been fully elucidated. The existing treatments fall short of offering adequate solution to drug resistance, so more effective approaches are desperately needed to improve existing therapeutic regimens. To overcome this hurdle, a number of strategies are being investigated, such as novel agents or drug carriers and combination treatment. In addition, some new therapeutics including gene therapy and immunotherapy may be promising for dealing with the resistance. In this article, we review the mechanisms of chemoresistance in breast cancer. Furthermore, the potential therapeutic methods to overcome the resistance were discussed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2019 Tipo de documento: Article